Personalis
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
6600 Dumbarton Cir, Fremont, California,...Phone Number
(650) 752-1300Website
www.personalis.comRevenue
$69.7 MillionStock Symbol
PSNLIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
2
2
1
About Personalis
Founded in 2011, Personalis is headquartered in Menlo Park, California. They are a provider of advanced genomic sequencing and analytic solutions to support the development of personalized cancer vaccines and other cancer immunotherapies.Explore more
Personalis Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Personalis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Personalis, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Personalis
Check out if Personalis is spiking on competitors!
Check if Personalis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Personalis launches new products
Click to see if Personalis had a recent Job posting/layoffs
Earning: See what the market has to say on Personalis recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Personalis has new funding data
Recommended Actions
Reach out to Masked Content who joined Personalis as Masked Content
Find more new buyers
Compare Similar Companies to Personalis
Compare insights from companies similar to Personalis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Personalis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Personalis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Personalis.
Personalis financials insights
Gather financial insights about Personalis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Series A
$20M
2013
Series B
$22M
2015
Series C
$33M
2019
Stock Offering
$140.8M
2024
Stock Offering
$17.7M
Personalis Tech Stack
A closer look at the technologies used by Personalis
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Person-Based
Stake & Stock Ownership, Finance
Person-Based
Earnings, Clinical Operations, Finance, Revenue Operations
Person-Based
Earnings, Finance
Person-Based
Clinical Operations
Personalis News & Media
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?
Tempus AI, Inc. (NASDAQ:TEM) rallied following a melanoma breakthrough reported by Moderna and Merck. The companies said their Phase 3 INTerpath-001 trial met its recurrence-free survival endpoint for the personalized cancer therapy intismeran autogene, also known as V940, combined with Keytruda. Detailed trial data remain pending. The read-through came from Personalis, which has supported the […]PSNL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Personalis to Tempus AI
We are investigating the fairness of the proposed sale of Personalis to Tempus AI for $16.25 per share in cash and common stock.PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus
Julie & Holleman LLP is investigating the proposed acquisition of Personalis.BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Luxfer Holdings PLC (NYSE – LXFR), Finward Bancorp (Nasdaq – FNWD), Personalis, Inc. (Nasdaq – PSNL), Distribution Solutions Group, Inc. (Nasdaq – DSGR)
BALA CYNWYD, Pa., July 27, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Personalis
Sign Up For FreeTo access detailed company insights
Founded in 2011, Personalis is headquartered in Menlo Park, California. They are a provider of advanced genomic sequencing and analytic solutions to support the development of personalized cancer vaccines and other cancer immunotherapies.... Read More
